By: Tido von Shoen-Angerer 24 November 2010 GlaxoSmithKline (GSK) was caught red-handed last week selling Synflorix, a vaccine that protects children from pneumococcal disease, for USD $150 in Uganda — European prices, in effect — when at the same time, the pharmaceutical company is withholding the same vaccine from an international subsidy that hopes to […]
Grant launches cervical cancer-free Indiana iniative
By: Indiana University School of Medicine 02 December 2010 Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation. Cervical Cancer-Free America (CCFA) is an initiative designed to raise awareness, increase […]
GSK, Binnopharm aim for Russia’s vaccine market
By: Tracy Staton 29 November 2010 GlaxoSmithKline has teamed up with another emerging markets partner. The drugmaker inked a deal with Russian vaccine firm JSC Binnopharm to make and sell several of its big vaccines in that country. It’s just the latest in a series of tie-ups in developing countries for GSK, which is pinning […]
FDA Panel Votes to Approve Second HPV Vaccine
Posted by: admin in ‘Pharmacy Drugs’ 16 October 2010 WASHINGTON – An FDA advisory panel today voted to recommend approval of GlaxoSmithKline‘s Cervarix vaccine for use against the two strains of human papillomavirus (HPV) that cause 70% of cervical cancers. In a separate action, the Vaccines and Related Biologics Committee recommended that the agency okay […]
Vaccine suspensions and drug disasters has made 2010 annus horribilis for GlaxoSmithKline
By: Christina England 07 September 2010 GlaxoSmithKline the drug giants, have spent the last few days trying to stay off the bottom of the FTSE 100, especially after the UK’s Medicines and Healthcare Products Regulatory Agency said that it’s diabetes treatment Avandia should be pulled from sale, over concerns that it can lead to heart […]